CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $11.05 ($33,150)
- 8-K Event Results of operations
- 8-K Event Acquisition or sale completed
- 4 Open-market sale Chief Technology Officer sold 20,000 shares at $10.94 ($218,800)
- 4 Shares withheld for taxes SVP Bus. and Corp. Dev. gave up 308 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,633 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 786 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 683 shares (to pay taxes)
- 4 Option exercise Chief Financial Officer acquired 40,000 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market sale Chief Technology Officer sold 897 shares at $13.53 ($12,136)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale President and CEO sold 20,000 shares at $13.19 ($263,800)
- 4 Open-market sale Chief Technology Officer sold 1,092 shares at an average $13.50 ($14,742)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,500 shares at $11.05 ($38,675)
Page 16 of 24 · 464 filings